Literature DB >> 10664826

Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.

M Kellner1, K Wiedemann, A Yassouridis, R Levengood, L S Guo, F Holsboer, R Yehuda.   

Abstract

BACKGROUND: Given the relationship between posttraumatic stress disorder (PTSD) and panic, it was of interest to examine whether panic provoking agents affect PTSD symptoms. We therefore investigated the behavioral and endocrine response of PTSD patients to the panicogen cholecystokinin tetrapeptide (CCK-4).
METHODS: Eight patients with PTSD (DSM-IV) received 50 micrograms CCK-4 intravenously in a placebo-controlled, double-blind balanced design. Provocation of panic, anxiety, and flashbacks was assessed. Plasma adrenocorticotropin (ACTH) and cortisol levels after CCK-4 were measured and compared to healthy subjects matched for age, gender, and provoked symptoms.
RESULTS: Despite significant effects of CCK-4 on anxiety and panic symptoms, no significant provocation of flashbacks emerged. CCK-4-induced panic symptoms showed an inverse correlation to trait dissociation. The ACTH response after CCK-4 was significantly lower in PTSD patients than in controls. Cortisol was similarly increased in both groups after CCK-4, but PTSD patients showed a more rapid decrease of stimulated cortisol concentrations.
CONCLUSIONS: Panic symptoms or heightened anxiety are not necessarily conditioned stimuli for the provocation of posttraumatic flashbacks. Further studies in PTSD with different panicogens should be controlled for the potential interference of trait dissociation. Our hormone data show further evidence for a corticotropin-releasing hormone (CRH) overdrive and enhanced negative glucocorticoid feedback in PTSD patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10664826     DOI: 10.1016/s0006-3223(99)00118-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Block of glucocorticoid synthesis during re-activation inhibits extinction of an established fear memory.

Authors:  Jacqueline Blundell; Cory A Blaiss; Diane C Lagace; Amelia J Eisch; Craig M Powell
Journal:  Neurobiol Learn Mem       Date:  2011-02-17       Impact factor: 2.877

Review 2.  Pharmacotherapy for post traumatic stress disorder (PTSD).

Authors:  Taryn Williams; Nicole J Phillips; Dan J Stein; Jonathan C Ipser
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

3.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

4.  Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.

Authors:  Peter Zwanzger; Maxim Zavorotnyy; Elena Gencheva; Julia Diemer; Harald Kugel; Walter Heindel; Tillmann Ruland; Patricia Ohrmann; Volker Arolt; Katharina Domschke; Bettina Pfleiderer
Journal:  Neuropsychopharmacology       Date:  2013-03-05       Impact factor: 7.853

5.  Temporal association of elevated cholecystokininergic tone and adolescent trauma is critical for posttraumatic stress disorder-like behavior in adult mice.

Authors:  Anu Joseph; Mingxi Tang; Takayoshi Mamiya; Qian Chen; Ling-Ling Yang; Jianwei Jiao; Na Yu; Ya-Ping Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

6.  Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

Authors:  Santiago J Ballaz; Michel Bourin; Huda Akil; Stanley J Watson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-09-14       Impact factor: 5.067

Review 7.  Pharmacotherapy for post traumatic stress disorder (PTSD).

Authors:  D J Stein; J C Ipser; S Seedat
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

8.  Bi-directional effect of cholecystokinin receptor-2 overexpression on stress-triggered fear memory and anxiety in the mouse.

Authors:  Qian Chen; Mingxi Tang; Takayoshi Mamiya; Heh-In Im; Xiaoli Xiong; Anu Joseph; Ya-Ping Tang
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

Review 9.  Gut-Brain Neuroendocrine Signaling Under Conditions of Stress-Focus on Food Intake-Regulatory Mediators.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

Review 10.  A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications.

Authors:  Lívea Dornela Godoy; Matheus Teixeira Rossignoli; Polianna Delfino-Pereira; Norberto Garcia-Cairasco; Eduardo Henrique de Lima Umeoka
Journal:  Front Behav Neurosci       Date:  2018-07-03       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.